Synmosa Biopharma Corporation

TPEX:4114 주식 보고서

시가총액: NT$14.6b

Synmosa Biopharma 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Chih-Hui Lin

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기19.5yrs
CEO 소유권1.0%
경영진 평균 재임 기간데이터 없음
이사회 평균 재임 기간5.5yrs

최근 관리 업데이트

Recent updates

Is Synmosa Biopharma Corporation (GTSM:4114) A Smart Pick For Income Investors?

Apr 04
Is Synmosa Biopharma Corporation (GTSM:4114) A Smart Pick For Income Investors?

If You Had Bought Synmosa Biopharma (GTSM:4114) Stock Three Years Ago, You Could Pocket A 22% Gain Today

Mar 08
If You Had Bought Synmosa Biopharma (GTSM:4114) Stock Three Years Ago, You Could Pocket A 22% Gain Today

Should Weakness in Synmosa Biopharma Corporation's (GTSM:4114) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Jan 31
Should Weakness in Synmosa Biopharma Corporation's (GTSM:4114) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Is Synmosa Biopharma (GTSM:4114) A Risky Investment?

Jan 05
Is Synmosa Biopharma (GTSM:4114) A Risky Investment?

Here's Why We Don't Think Synmosa Biopharma's (GTSM:4114) Statutory Earnings Reflect Its Underlying Earnings Potential

Dec 09
Here's Why We Don't Think Synmosa Biopharma's (GTSM:4114) Statutory Earnings Reflect Its Underlying Earnings Potential

CEO 보상 분석

Chih-Hui Lin 의 보수는 Synmosa Biopharma 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

NT$718m

Jun 30 2024n/an/a

NT$689m

Mar 31 2024n/an/a

NT$650m

Dec 31 2023n/an/a

NT$595m

Sep 30 2023n/an/a

NT$585m

Jun 30 2023n/an/a

NT$562m

Mar 31 2023n/an/a

NT$800m

Dec 31 2022n/an/a

NT$799m

Sep 30 2022n/an/a

NT$735m

Jun 30 2022n/an/a

NT$693m

Mar 31 2022n/an/a

NT$368m

Dec 31 2021n/an/a

NT$304m

Sep 30 2021n/an/a

NT$288m

Jun 30 2021n/an/a

NT$293m

Mar 31 2021n/an/a

NT$634m

Dec 31 2020NT$5mNT$4m

NT$638m

보상 대 시장: TW 시장에서 비슷한 규모의 회사에 비해 Chih-Hui 의 총 보상이 합리적인지 여부를 입증하기에는 데이터가 부족합니다.

보상과 수익: Chih-Hui 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.


CEO

Chih-Hui Lin (41 yo)

19.5yrs

테뉴어

NT$4,710,000

보상

Mr. Chih-Hui Lin serves as Chairman at Synmosa Biopharma Corporation and serves as its Director since May 16, 2019. He serves as President, Managerial officer and General Manager of the Synmosa Biopharma C...


이사회 구성원

이름위치테뉴어보상소유권
Chih-Hui Lin
Chairman19.5yrsNT$4.71m1.02%
NT$ 149.7m
San-Chien Tu
Additional Independent Director1.3yrs데이터 없음데이터 없음
Xiang-Lang Liu
Independent Director21.8yrsNT$1.07m데이터 없음
Xiu-Mei Lin
Independent Director5.5yrsNT$1.19m0.0011%
NT$ 156.5k
You-Peng Zhang
Representative Director5.5yrsNT$1.09m1.01%
NT$ 147.6m
Li-Wen Huang
Representative Director15.8yrsNT$1.09m0.96%
NT$ 141.0m
Huilan Qiu
Independent Directorless than a year데이터 없음1.92%
NT$ 281.1m

5.5yrs

평균 재임 기간

42yo

평균 연령

경험이 풍부한 이사회: 4114 의 이사회경험(평균 재직 기간 5.5 년)으로 간주됩니다.